Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Soffer

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Current Atherosclerosis Reports|September 13, 2021
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and PancreatitisPatricia Hernandez, Neena Passi, Taher Modarressi, et al.
Proceedings of the Western Pharmacology Society|June 24, 2009
Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4Sotir Polena, Manish P Gupta, Hafiza Shaikh, et al.
JACC. Case Reports|October 3, 2025
Transcatheter Mitral Valve Replacement With LAMPOONJulien Feghaly, Naji Maaliki, Yixin Zhang, et al.
Journal of the American Heart Association|December 21, 2020
Racial/Ethnic Disparities in Screening for and Awareness of High Cholesterol Among Pregnant Women Receiving Prenatal CareReed Mszar, Dipika J Gopal, Rupa Chowdary, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2005
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndromePhilippe O Szapary, LeAnne T Bloedon, Frederick F Samaha, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 30, 2003
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?Daniel Soffer, Issam Moussa, Kishore J Harjai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled studyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
Journal of Clinical Lipidology|July 9, 2019
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid AssociationJennifer G Robinson, Manju Bengularu Jayanna, Alan S Brown, et al.
Journal of Lipid Research|November 12, 2010
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionCatherine E Watson, Nicole Weissbach, Lise Kjems, et al.
JACC. Cardiovascular Interventions|August 5, 2019
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Current Atherosclerosis Reports|September 13, 2021
Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and PancreatitisPatricia Hernandez, Neena Passi, Taher Modarressi, et al.
Proceedings of the Western Pharmacology Society|June 24, 2009
Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4Sotir Polena, Manish P Gupta, Hafiza Shaikh, et al.
JACC. Case Reports|October 3, 2025
Transcatheter Mitral Valve Replacement With LAMPOONJulien Feghaly, Naji Maaliki, Yixin Zhang, et al.
Journal of the American Heart Association|December 21, 2020
Racial/Ethnic Disparities in Screening for and Awareness of High Cholesterol Among Pregnant Women Receiving Prenatal CareReed Mszar, Dipika J Gopal, Rupa Chowdary, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2005
Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndromePhilippe O Szapary, LeAnne T Bloedon, Frederick F Samaha, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 30, 2003
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: do we need more aggressive dosing regimens in unstable angina?Daniel Soffer, Issam Moussa, Kishore J Harjai, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled studyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
Journal of Clinical Lipidology|July 9, 2019
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid AssociationJennifer G Robinson, Manju Bengularu Jayanna, Alan S Brown, et al.
Journal of Lipid Research|November 12, 2010
Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL functionCatherine E Watson, Nicole Weissbach, Lise Kjems, et al.
JACC. Cardiovascular Interventions|August 5, 2019
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Pageof 4